Indian Journal of Clinical Anaesthesia
  • Year: 2016
  • Volume: 3
  • Issue: 3

Comparison of Ondansetron, Dexamethasone and Ondansetron Plus Dexamethasone For The Prevention of Post-operative Nausea and Vomiting after Laparoscopic Cholecystectomy

  • Author:
  • Suman Chattopadhyay1,, Ananya Biswas2, SK Samim Ferdows3, Dilip Kumar Bhowmik4, Swagata Dey5, Biswanath Biswas6
  • Total Page Count: 5
  • Page Number: 459 to 463

1Associate Professor, Midnapore Medical College, Paschim Midnapur,

2Assistant Professor, Dept. of Anatomy, Malda Medical College, Malda

3Assistant Professor, Dept. of Community Medicine, IQ City Medical College, Durgapur

4Assistant Professor, Dept. of Anaesthesia, IQ City Medical College, Durgapur

5Senior Resident, Dept. of Anaesthesia, IQ City Medical College, Durgapur

6Professor & HOD, Dept. of Anaesthesia, IQ City Medical College, Durgapur

*Corresponding Author: Email: sumanc24@gmail.com

Online published on 25 May, 2017.

Abstract

Laparoscopic cholecystectomy is associated with an appreciably high rate of postoperative nausea & vomiting (PONV) which is considered as a reason of patient's delay in discharge and disability aggravation. This study was designed to compare the effectiveness of Ondansetron, Dexamethason and Ondansetron plus Dexamethasone as an antiemetic prophylaxis for preventing PONV in patients after laparoscopic cholecystectomy.

In this randomised double blind study, 153 patients of both sexes of ASA I and II aged between 16 to 60 yrs received 4 mg Ondansetron (Group O, n = 50), 8 mg Dexamethason (Group D, n =51) or Ondansetron 4 mg plus Dexamethasone 8 mg (Group OD, n=52) intravenously immediately before induction of anaesthesia. Perioperative care was standardised in all patients. Patient was then observed for 24 hours postoperatively for any episode of PONV and any adverse effects of the study drugs.

A complete response (defined as no PONV and no need for another antiemetic) was achieved in 62% of the patients receiving Ondansetron, 64.7% of the patient receiving Dexamethasone and in 84.6% of patients receiving Ondansetron plus Dexamethasone (P<0.05). The overall cumulative incidences (0–24 hrs) of PONV were 40% in Ondansetron group, 37.3% in the Dexamethasone group and 15.4% in combination group (P<0.05). No difference in adverse events was observed in between group.

We concluded that combination of Ondansetron plus Dexamethasone is better than each drug alone as an antiemetic prophylaxis against PONV following laparoscopic cholecystectomy.

Keywords

Laparoscopic cholecystectomy, Prophylactic, Antiemetic, Ondansetron, Dexamethasone, Nausea, Vomiting